Netarsudil 0.02 % Ophthalmic Solution
RxNorm 1992868
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1992868 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: netarsudil 0.02 % Ophthalmic Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Netarsudil 0.2 mg/ML Ophthalmic Solution
(Atom ID: 10775554)
PSNPrescribable
Prescribable Name (PSN):
Netarsudil 0.02 % Ophthalmic Solution
(Atom ID: 10775561)
SYPrescribable
Synonym (SY):
Netarsudil 0.02 % Ophthalmic Solution
(Atom ID: 10775560)
SYPrescribable
Synonym (SY):
Netarsudil 0.2 mg/ML (as netarsudil dimesylate 0.28 mg/ML) Ophthalmic Solution
(Atom ID: 10775559)
PTPrescribable
Designated preferred name (PT):
Netarsudil 200 microgram/mL eye drops solution
(Atom ID: 12903349)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely netarsudil 200 microgram/1 mL conventional release solution for eye drops (clinical drug)
(Atom ID: 12903838)
Patient Education
Netarsudil Ophthalmic
Netarsudil ophthalmic is used to treat glaucoma (a condition in which increased pressure in the eye can lead to gradual loss of vision) and ocular hypertension (a condition which causes increased pressure in the eye). Netarsudil is in a class of medications called rho kinase inhibitors. It works by lowering the pressure in the eye by increasing the flow of natural eye fluids out of the eye.
[Learn More]
* Please review the disclaimer below.